Name:
Suilimivivens aceti
DSM No.:
102261, Type strain dsm-102261 dsm102261 dsm 102261 Suilimivivens aceti
Strain designation:
Sanger_18
Other collection no.
or WDCM no.:
JCM 34982
Isolated from:
faeces from healthy human
Country:
United Kingdom of Great Britain and Northern Ireland
Cambridgeshire, Hinxton
Date of sampling:
13.02.2014
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Sanger_18 <- H. Browne {2014}
Genbank accession numbers:
Summary and
additional information:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Sanger_18 <- H. Browne {2014}. Faeces from healthy human; United Kingdom, Cambridgeshire, Hinxton. Type strain. Taxonomy/description (30548, 40121). Sequence accession no. draft genome (raw reads): ERR1022342. (Medium 110a or Medium 1611, 37°C, anaerobic).
Risk group:
1 (provisional classification by DSMZ)
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.
